Azelaic AcidvsCentella Asiatica

Azelaic acid exhibits multi-modal activity: (1) Tyrosinase inhibition—competitively inhibits tyrosinase selectively in hyperactive melanocytes (melasma, PIH) while sparing normal ones; may involve mitochondrial enzyme interference in dysregulated melanocytes. (2) Antimicrobial—bacteriostatic against Cutibacterium acnes by inhibiting bacterial protein synthesis. (3) Comedolytic—normalizes follicular keratinization, reducing hyperkeratinization and corneocyte cohesion; may modulate keratinocyte differentiation. (4) Anti-inflammatory—scavenges ROS, inhibits neutrophil free radicals, reduces pro-inflammatory cytokines. Inhibits 5-alpha-reductase in sebocytes, potentially reducing sebum. Multi-pathway activity explains efficacy in acne, rosacea, and hyperpigmentation. Safe during pregnancy.

The four key triterpenoid saponins—madecassoside, asiaticoside, madecassic acid, and asiatic acid—exert distinct but complementary mechanisms. Madecassoside and asiaticoside are anti-inflammatory: they inhibit NF-κB nuclear translocation and IκB kinase activity, reducing TNF-α, IL-6, and IL-1β production in keratinocytes and dermal cells. Madecassic acid and asiatic acid (the aglycone forms) stimulate type I and III collagen synthesis in fibroblasts by upregulating collagen gene expression and procollagen production. All four compounds promote wound healing by stimulating angiogenesis via VEGF (vascular endothelial growth factor) upregulation, fibroblast proliferation and migration, and extracellular matrix remodeling. Centella extracts also increase superoxide dismutase (SOD) and catalase activity in skin cells, enhancing endogenous antioxidant defense. The triterpenes may modulate TGF-β and Smad signaling. TECA (Titrated Extract of Centella Asiatica) standardizes these actives for consistent clinical efficacy.